180 related articles for article (PubMed ID: 17544170)
21. Signaling mechanisms for alpha2-adrenergic inhibition of PACAP-induced growth hormone secretion and gene expression grass carp pituitary cells.
Wang X; Chu MM; Wong AO
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1750-62. PubMed ID: 17311897
[TBL] [Abstract][Full Text] [Related]
22. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment.
Shioda S; Ohtaki H; Nakamachi T; Dohi K; Watanabe J; Nakajo S; Arata S; Kitamura S; Okuda H; Takenoya F; Kitamura Y
Ann N Y Acad Sci; 2006 Jul; 1070():550-60. PubMed ID: 16888224
[TBL] [Abstract][Full Text] [Related]
23. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
Zhang W; Duan W; Cheung NS; Huang Z; Shao K; Li QT
J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
[TBL] [Abstract][Full Text] [Related]
24. PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway.
Kienlen Campard P; Crochemore C; René F; Monnier D; Koch B; Loeffler JP
DNA Cell Biol; 1997 Mar; 16(3):323-33. PubMed ID: 9115641
[TBL] [Abstract][Full Text] [Related]
25. PACAP decides neuronal laminar fate via PKA signaling in the developing cerebral cortex.
Ohtsuka M; Fukumitsu H; Furukawa S
Biochem Biophys Res Commun; 2008 May; 369(4):1144-9. PubMed ID: 18346455
[TBL] [Abstract][Full Text] [Related]
26. Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation.
Fila T; Trazzi S; Crochemore C; Bartesaghi R; Ciani E
J Biol Chem; 2009 May; 284(22):15325-38. PubMed ID: 19346254
[TBL] [Abstract][Full Text] [Related]
27. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
[TBL] [Abstract][Full Text] [Related]
28. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development.
Vaudry D; Gonzalez BJ; Basille M; Fournier A; Vaudry H
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9415-20. PubMed ID: 10430957
[TBL] [Abstract][Full Text] [Related]
29. Cerebellar cortical-layer-specific control of neuronal migration by pituitary adenylate cyclase-activating polypeptide.
Cameron DB; Galas L; Jiang Y; Raoult E; Vaudry D; Komuro H
Neuroscience; 2007 May; 146(2):697-712. PubMed ID: 17383102
[TBL] [Abstract][Full Text] [Related]
30. PACAP support of neuronal survival requires MAPK- and activity-generated signals.
Pugh PC; Margiotta JF
Mol Cell Neurosci; 2006 Mar; 31(3):586-95. PubMed ID: 16431129
[TBL] [Abstract][Full Text] [Related]
31. Possible implication of the transcriptional regulator Id3 in PACAP-induced pro-survival signaling during PC12 cell differentiation.
Ghzili H; Grumolato L; Thouënnon E; Vaudry H; Anouar Y
Regul Pept; 2006 Nov; 137(1-2):89-94. PubMed ID: 16928405
[TBL] [Abstract][Full Text] [Related]
32. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells.
Kageyama K; Hanada K; Iwasaki Y; Sakihara S; Nigawara T; Kasckow J; Suda T
J Endocrinol; 2007 Nov; 195(2):199-211. PubMed ID: 17951532
[TBL] [Abstract][Full Text] [Related]
33. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT
Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848
[TBL] [Abstract][Full Text] [Related]
34. What is the role of PACAP in gonadotrope function?
Counis R; Laverrière JN; Garrel-Lazayres G; Cohen-Tannoudji J; Larivière S; Bleux C; Magre S
Peptides; 2007 Sep; 28(9):1797-804. PubMed ID: 17601637
[TBL] [Abstract][Full Text] [Related]
35. PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex.
Vaudry D; Gonzalez BJ; Basille M; Pamantung TF; Fournier A; Vaudry H
Ann N Y Acad Sci; 2000; 921():293-9. PubMed ID: 11193838
[TBL] [Abstract][Full Text] [Related]
36. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
Dejda A; Jozwiak-Bebenista M; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
[TBL] [Abstract][Full Text] [Related]
37. The effects of PACAP on neural cell proliferation.
Meyer DK
Regul Pept; 2006 Nov; 137(1-2):50-7. PubMed ID: 17011642
[TBL] [Abstract][Full Text] [Related]
38. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways.
Rácz B; Gallyas F; Kiss P; Tóth G; Hegyi O; Gasz B; Borsiczky B; Ferencz A; Roth E; Tamás A; Lengvári I; Lubics A; Reglodi D
Regul Pept; 2006 Nov; 137(1-2):20-6. PubMed ID: 16945433
[TBL] [Abstract][Full Text] [Related]
39. Novel stable PACAP analogs with potent activity towards the PAC1 receptor.
Bourgault S; Vaudry D; Botia B; Couvineau A; Laburthe M; Vaudry H; Fournier A
Peptides; 2008 Jun; 29(6):919-32. PubMed ID: 18353507
[TBL] [Abstract][Full Text] [Related]
40. Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages.
Sokolowska P; Nowak JZ
Ann N Y Acad Sci; 2006 Jul; 1070():566-9. PubMed ID: 16888226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]